1. Awareness of hepatitis B virus reactivation among physicians administering immunosuppressive treatment and related clinical practices
- Author
-
Sinan Ozturk, Onur Toka, Sabahat Ceken, Kiymet Gundogdu, Suda Tekin, Rıza Aytaç Çetinkaya, Nese Saltoglu, Gülden Ersöz, Ismail Necati Hakyemez, Sukran Kose, Selmin Dirgen Çaylak, Ziya Kuruüzüm, Nesrin Türker, Huseyin Kaya Suer, Zerrin Asci, Mehmet Reşat Ceylan, Alper Şener, Sua Sumer, Onur Ural, Ercan Yenilmez, Neşe Demirtürk, Aysel Kocagul Celikbas, Dilara Inan, Oya Özlem Eren Kutsoylu, Selcan Arslan Ozel, Asli Haykir Solay, Celal Ayaz, Özgür Günal, Eyup Arslan, İrem Akdemir Kalkan, Bilgehan Aygen, Ayse Batirel, Sıla Akhan, Mehtap Aydin, Bahar Ormen, Zuhal Yesilbag, Ergenekon Karagoz, Murat Sayan, Necla Tulek, Hacer Deniz Ozkaya, Gule Aydin, Ali Acar, Pinar Korkmaz, Fatma Yılmaz Karadağ, Vuslat Ecem Gunes Altiparmak, Ayten Kadanali, Nazlim Aktug Demir, Meliha Çağla Sönmezer, Gulsen Yoruk, Fatma Sirmatel, Koruk, Süda Tekin, Korkmaz, Pınar, Demirtürk, Neşe, Aydın, Güle, Çeken, Sabahat, Aygen, Bilgehan, Toka, Onur, Gündoğdu, Kıymet, Kocagül-Çelikbaş, Aysel, İnan, Dilara, Kuruüzüm, Ziya, Eren-Kutsoylu, Oya Özlem, Batırel, Ayşe, Sırmatel, Fatma, Ersöz, Gülden, Hakyemez, İsmail Necati, Aşçı, Zerrin, Yeşilbağ Zuhal, Sönmezer, Meliha Çağla, Tülek, Necla, Örmen, Bahar, Yılmaz-Karadağ, Fatma, Yörük, Gülşen, Türker, Nesrin, Özkaya, Hacer Deniz, Akdemir-Kalkan, İrem, Süer, Hüseyin Kaya, Saltoğlu, Neşe, Şener, Alper, Yenilmez, Ercan, Çetinkaya, Rıza Aytaç, Arslan-Özel, Selcan, Ayaz, Celal, Karagöz, Ergenekon, Aydın, Mehtap, Acar, Ali, Arslan, Eyüp, Ceylan, Mehmet Reşat, Aktuğ-Demir, Nazlım, Dirgen-Çaylak, Selmin, Günal, Özgür, Haykır-Solay, Aslı, Öztürk, Sinan, Ural, Onur, Sümer, Süa, Kadanalı, Ayten, Güneş-Altıparmak, Vuslat Ecem, Akhan, Sıla, Sayan, Murat, Köse, Şükran, Koç University Hospital, Selçuk Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Demir, Nazlım Aktuğ, Sümer, Şua, MÜ, HAKYEMEZ, İSMAİL NECATİ, BAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, and İÜC, Cerrahpaşa Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
- Subjects
Microbiology (medical) ,Hepatitis B virus ,Immunosuppressive treatment ,reactivation ,immunosuppression ,business.industry ,virus diseases ,Medicine, general and internal ,Microbiology ,İmmünosüpresyon ,Reaktivasyon ,medicine.disease_cause ,Reactivation ,Hepatitis B ,digestive system diseases ,Infectious Diseases ,Immunology ,Medicine ,KORKMAZ P., Demirturk N., Aydin G., Ceken S., AYGEN B., TOKA O., GÜNDOĞDU K., Kocagul-Celikbas A., İNAN D., KURUÜZÜM Z., et al., -Awareness of Hepatitis B Virus Reactivation Among Physicians Administering Immunosuppressive Treatment and Related Clinical Practices-, KLIMIK JOURNAL, cilt.32, ss.146-153, 2019 ,business ,Immunosuppression - Abstract
Objective: this study aimed to evaluate the awareness and knowledge levels of all physicians administering immunosuppressive treatment concerning hepatitis B virus (HBV) reactivation, and draw attention to the importance of the subject through evaluation. Methods: the study was carried out by infectious diseases and clinical microbiology specialists in 37 health centers, and it was performed in Turkey between January and March 2017. All specialists providing a written consent and working in the departments of Medical Oncology, Hematology, Dermatology and Venereology, Physical Medicine and Rehabilitation, and Rheumatology of each study center were included in the study. Results: a total of 430 physicians participated in the study. Their mean age was 39.87 +/- 7.42 years, and 47.9% of them were males. During their career, 39.3% of these physicians had encountered patients developing HBV reactivation while receiving immunosuppressive treatment. The rate of encountering patients who died due to HBV reactivation was 6.5%. 97% of physicians who participated, considered the risk of HBV reactivation to be important. 70.2% of physicians stated that guidelines related to HBV reactivation and antiviral treatment for these patients were discussed in the congresses they participated, regarding their specialties. The rate of performing hepatitis screening among physicians whose patients developed HBV reactivation was statistically significantly higher than those physicians who had no patients with HBV reactivation (p, NA
- Published
- 2019